Behavior therapy augments response of patients with obsessive-compulsive disorder responding to drug treatment

Journal of Clinical Psychiatry

Volumn 66, Issue 9, 2005, Pages 1169-1175

  Tenneij, Nienke H ^a,b   Van Megen, Harold J G M ^a   Denys, Damiaan A J P ^a   Westenberg, Herman G M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PAROXETINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; BEHAVIOR THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSESSIVE COMPULSIVE DISORDER; PATIENT ATTITUDE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; SCORING SYSTEM; TREATMENT OUTCOME;

EID: 26644458315     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v66n0913     Document Type: Article

References (25)

1. Weissman MM, Bland RC, Canino GJ, et al. The cross national epidemiology of obsessive compulsive disorder. J Clin Psychiatry 1994;55 (suppl 3):5-10
2. Kolada JL, Bland RC, Newman SC. Epidemiology of psychiatric disorders in Edmonton: obsessive-compulsive disorder. Acta Psychiatr Scand Suppl 1994;376:24-35
3. Expert Consensus Guideline Series: Treatment of Obsessive-Compulsive Disorder. J Clin Psychiatry 1997;58(suppl 4):2-72
4. van Balkom AJ, van Oppen P, Vermeulen AWA, et al. A meta-analysis on the treatment of obsessive-compulsive disorder: a comparison of antidepressants, behavior, and cognitive therapy. Clin Psychol Rev 1994;14: 359-381
5. Marks IM, Stern RS, Mawson D, et al. Clomipramine and exposure for obsessive-compulsive rituals, 1. Br J Psychiatry 1980;136:1-25
6. Marks IM, Lelliott P, Basoglu M, et al. Clomipramine, self-exposure and therapist-aided exposure for obsessive-compulsive rituals. Br J Psychiatry 1988;152:522-534
7. Cottraux J, Mollard E, Bouvard M, et al. A controlled study of fluvoxamine and exposure in obsessive-compulsive disorder. Int Clin Psychopharmacol 1990;5:17-30
8. Foa EB, Liebowitz MR, Kozak MJ, et al. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. Am J Psychiatry 2005;162:151-161
9. Hohagen F, Winkelmann G, Rasche-Ruchle H, et al. Combination of behavior therapy with fluvoxamine in comparison with behaviour therapy and placebo: results of a multicenter study. Br J Psychiatry Suppl 1998;35:71-78
10. van Balkom AJ, de Haan E, van Oppen P, et al. Cognitive and behavioral therapies alone versus in combination with fluvoxamine in the treatment of obsessive compulsive disorder. J Nerv Ment Dis 1998;186:492-499
11. Kampman M, Keijsers GP, Hoogduin CA, et al. Addition of cognitive-behavior therapy for obsessive-compulsive disorder patients non-responding to fluoxetine. Acta Psychiatr Scand 2002;106:314-319
12. Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale, 1: development, use and reliability. Arch Gen Psychiatry 1989;46:1006-1011
13. Goodman WK, Price LH. Assessment of severity and change in obsessive-compulsive disorder. Psychiatr Clin North Am 1992;15: 861-869
14. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
15. Denys D, van der Wee N, van Megen HJ, et al. A double blind comparison of venlafaxine and paroxetine in obsessive-compulsive disorder. J Clin Psychopharmacol 2003;23:568-575
16. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278-296
17. Hamilton M. Diagnosis and rating of anxiety. Br J Psychiatry 1959;3:67-69
18. Ballenger JC. Treatment of anxiety disorders to remission. J Clin Psychiatry 2001;62(suppl 12):5-9
19. Greist JH. An integrated approach to treatment of obsessive compulsive disorder. J Clin Psychiatry 1992;53(suppl 4):38-41
20. The Pediatric OCD Treatment Study (POTS) Team. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder. JAMA 2004;292:1969-1975
21. Nestadt G, Samuels J, Riddle MA, et al. The relationship between obsessive-compulsive disorder and anxiety and affective disorder: results from the Johns Hopkins OCD family study. Psychol Med 2001;31:481-487
22. Carter AS, Pollock RA, Suvak MK, et al. Anxiety and major depression comorbidity in a family study of obsessive-compulsive disorder. Depress Anxiety 2000;20:165-174
23. Lindsay M, Crino R, Andrews G. Controlled trial of exposure and response prevention in obsessive-compulsive disorder. Br J Psychiatry 1997;171:135-139
24. Kordon A, Kahl KG, Broocks A. Clinical outcome in patients with obsessive-compulsive disorder after discontinuation of SRI treatment: results from a two-year follow-up. Eur Arch Psychiatry Clin Neurosci 2005;255:48-50
25. Simpson HB, Liebowitz MR, Foa EB, et al. Post-treatment effects of exposure therapy and clomipramine in obsessive-compulsive disorder. Depress Anxiety 2004;19:225-233